Article
siRNAs: Potential therapeutic agents against Hepatitis C Virus
6 Jun 2011
Abstract excerpt
Hepatitis C virus is a major cause of chronic liver diseases which can lead to permanent liver damage, hepatocellular carcinoma and death. The presently available treatment with interferon plus ribavirin, has limited benefits due to adverse side effects such as anemia, depression and "flu-like" symptoms. Needless to mention, the effectiveness of interferon therapy is predominantly, if not exclusively, limited to...
Topics
Join the communities discussing this publication.